Literature DB >> 9529103

Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice.

T Kurioka1, Y Yunou, E Kita.   

Abstract

Infection with Shiga toxin (Stx)-producing enterohemorrhagic Escherichia coli is increasing among children. In this study, 5-week-old C57BL/6 mice with protein calorie malnutrition (PCM) that had been fed a 5% protein diet for 2 weeks since ablactation were inoculated intragastrically with 2 x 106 CFU of Stx-producing E. coli O157:H7. More than 75% of infected mice with PCM died by 10 days postinfection. Infected mice with PCM developed neurologic symptoms 5 days after infection, while well-nourished control mice receiving a 25% protein diet did not. In the intestinal tracts of infected mice with PCM, inoculated E. coli O157:H7 multiplied between days 2 and 4 of infection, with a peak of growth at day 4. Although the pathogens were not culturable from the stool after day 7, 0157 lipopolysaccharide was detectable in the stool by enzyme-linked immunosorbent assay even after day 8. Stx was detectable in the stool after day 2 of infection and increased in proportion to the growth of inoculated organisms. The maximal production of Stx occurred at 4 days postchallenge, and Stx was detectable in the blood on days 3 to 5. In contrast, well-nourished control mice survived the infection, and all of them remained well even after 3 weeks of infection. In these control mice, inoculated E. coli O157:H7 disappeared from the stool before day 3. Stx was not detectable in the stool and blood of infected control mice at any time from day 1 through day 8. Histologically, cerebral hemorrhages seemed to be the cause of acute death of infected mice with PCM. Immunocytochemical staining demonstrated the positive immunoreaction to Stx at the alveus and stratum pyramidale of the hippocampus and in renal tubules of infected malnourished mice. Such immunoreactions were not found in tissues from infected control mice. Histological study of the intestinal epithelium before infection showed that PCM severely affected the development of intestinal epithelia. These findings strongly indicate that PCM-induced nondevelopment of intestinal physical barrier is one of the predisposing factors for infection with Stx-producing E. coli O157:H7 in mice and suggest that our mouse model may explain the high incidence of infection with Stx-producing E. coli O157:H7 in the children whose intestinal epithelia have not yet completely developed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529103      PMCID: PMC108110     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

2.  Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.

Authors:  T Waddell; S Head; M Petric; A Cohen; C Lingwood
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

3.  Two distinct toxins active on Vero cells from Escherichia coli O157.

Authors:  S M Scotland; H R Smith; B Rowe
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

4.  Cloning of genes determining the production of vero cytotoxin by Escherichia coli.

Authors:  G A Willshaw; H R Smith; S M Scotland; B Rowe
Journal:  J Gen Microbiol       Date:  1985-11

5.  Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets.

Authors:  S Tzipori; C W Chow; H R Powell
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

6.  Hepatic lesions in experimental Campylobacter jejuni infection of mice.

Authors:  E Kita; N Katsui; K Nishi; M Emoto; Y Yanagase; S Kashiba
Journal:  J Gen Microbiol       Date:  1986-11

7.  Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP).

Authors:  D M Morrison; D L Tyrrell; L D Jewell
Journal:  Am J Clin Pathol       Date:  1986-07       Impact factor: 2.493

8.  A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome.

Authors:  M M Levine; J G Xu; J B Kaper; H Lior; V Prado; B Tall; J Nataro; H Karch; K Wachsmuth
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

9.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

10.  Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7.

Authors:  D H Francis; R A Moxley; C Y Andraos
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

View more
  20 in total

1.  An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

Authors:  Miho Watanabe-Takahashi; Toshio Sato; Taeko Dohi; Noriko Noguchi; Fumi Kano; Masayuki Murata; Takashi Hamabata; Yasuhiro Natori; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

2.  Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions.

Authors:  Kazue Tsutsuki; Miho Watanabe-Takahashi; Yasuaki Takenaka; Eiji Kita; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

Review 3.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.

Authors:  Kiyotaka Nishikawa; Koji Matsuoka; Eiji Kita; Noriko Okabe; Masashi Mizuguchi; Kumiko Hino; Shinobu Miyazawa; Chisato Yamasaki; Junken Aoki; Sachio Takashima; Yoshio Yamakawa; Masahiro Nishijima; Daiyo Terunuma; Hiroyoshi Kuzuhara; Yasuhiro Natori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Mouse model of enteropathogenic Escherichia coli infection.

Authors:  Suzana D Savkovic; Jennilee Villanueva; Jerrold R Turner; Kristina A Matkowskyj; Gail Hecht
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  The actions of Shiga toxin-2 administration into the brain on renal sympathetic nerve activity.

Authors:  Akio Nakamura; Akira Imaizumi; Takao Kohsaka; Chunlong Huang; Chunhua Huang; Edward J Johns
Journal:  Clin Exp Nephrol       Date:  2011-12-03       Impact factor: 2.801

7.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

8.  Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits.

Authors:  M Ogawa; K Shimizu; K Nomoto; M Takahashi; M Watanuki; R Tanaka; T Tanaka; T Hamabata; S Yamasaki; Y Takeda
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Tonia Zangari; Erica E Carroll; Alison D O'Brien
Journal:  Microb Pathog       Date:  2010-01-22       Impact factor: 3.738

10.  Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.

Authors:  Kathryn A Eaton; David I Friedman; Gayle J Francis; Jessica S Tyler; Vincent B Young; Jennifer Haeger; Galeb Abu-Ali; Thomas S Whittam
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.